Immigration and screening programs for hemoglobinopathies in Italy, Spain and Turkey

Area of Science:

• * Hematology
• * Public Health
• * Migration Medicine

Background:

• * Sickle cell disease (SCD) and thalassemias are the most prevalent monogenic diseases globally.
• * Europe and Turkey have seen a significant increase in migrant and refugee populations.
• * Established programs for hemoglobinopathies exist in endemic regions and countries with long-standing migrant populations.

Purpose of the Study:

• * To summarize the experiences of managing hemoglobinopathies in migrant, asylum seeker, and refugee populations.
• * To highlight the implementation of preventive and diagnostic programs for these groups.
• * To share insights from Italy, Spain, and Turkey regarding these health initiatives.

Main Methods:

• * Review and synthesis of experiences from healthcare systems in Italy, Spain, and Turkey.
• * Focus on programs targeting immigrant populations with hemoglobinopathies.
• * Analysis of established practices in managing inherited blood disorders.

Main Results:

• * Successful implementation of preventive and diagnostic programs for hemoglobinopathies in migrant populations.
• * Adaptation of existing healthcare strategies to address the needs of asylum seekers and refugees.
• * Documented experiences provide a basis for future public health interventions.

Conclusions:

• * Integrated approaches are effective in managing hemoglobinopathies among diverse populations.
• * Continued development and sharing of best practices are crucial for public health.
• * Addressing genetic blood disorders in migrant populations requires tailored and accessible healthcare solutions.